- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
GE HealthCare Launches Multi-Purpose Versana Premier Ultrasound
The new ultrasound platform reportedly offers a combination of enhanced imaging and AI-enabled tools to facilitate improved workflow efficiency.
The emerging artificial intelligence (AI)-enabled ultrasound system Versana Premier may promote improved imaging and efficiency across a variety of clinical settings.
In addition to fostering up to a 38 percent improvement in workflow efficiency, the Versana Premier ultrasound offers Whizz technology that offers real-time image optimization, according to GE HealthCare, the manufacturer of Versana Premier.
The newly launched Versana Premier ultrasound device reportedly offers automated labeling for transabdominal ultrasound views and provides 3D/4D capabilities for capturing fetal development, according to GE HealthCare, the manufacturer of Versana Premier. (Image courtesy of GE HealthCare.)
The company noted the FDA-cleared ultrasound device also provides AI-powered automated labeling for transabdominal ultrasound views as well as volume calculations. For OBGYN imaging, GE HealthCare said the Versana Premier features Whizz RenderLive and V-Live 2.0 enable clinicians to obtain 3D and 4D imaging of fetal development.
“Versana Premier is remarkably user-friendly and image quality in B-Mode is easy to optimize, making it possible to create amazing images," said Martin Altersberger, M.D., the director of the Echo Laboratory at State Hospital Steyr in Steyr, Austria. "The ultrasound system integrates advanced functions with optimized image quality and educational resources, which can be used in various settings. It can, therefore, adequately support clinicians in a wide range of assessments and diagnoses.”
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Ultrasound Device Garners FDA De Novo Nod for Kidney Stone Clearance
November 14th 2024Emerging research demonstrated that the Stone Clear device, which facilitates post-lithotripsy clearance of kidney stone fragments, led to a 70 percent lower risk of relapse in comparison to observation in a control group.
